Collins Cynthia

CIK 00014056928 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001405692

Recent Transactions

50 trades

Award
MAXCYTE, INC.$MXCT
Common Stock
2026-06-17+30,421→ 111,310 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2026-06-17+49,579→ 49,579 total
Award
CODEXIS, INC.$CDXS
Stock Option (Right to Buy)
2026-06-17+66,350→ 66,350 total
Exercise/Conversion
Certara, Inc.$CERT
Restricted Stock Units
2026-05-14−15,757→ 0 total
Exercise/Conversion
Certara, Inc.$CERT
Common Stock
2026-05-14+15,757→ 51,846 total
Award
MAXCYTE, INC.$MXCT
Common Stock
2025-06-18+29,210→ 80,889 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2025-06-18+50,790→ 50,790 total
Award
CODEXIS, INC.$CDXS
Common Stock
2025-06-10+40,983→ 112,157 total
Exercise/Conversion
Certara, Inc.$CERT
Restricted Stock Units
2025-05-21−11,928→ 0 total
Award
Certara, Inc.$CERT
Restricted Stock Units
2025-05-21+15,757→ 15,757 total
Exercise/Conversion
Certara, Inc.$CERT
Common Stock
2025-05-21+11,928→ 36,089 total
Award
CODEXIS, INC.$CDXS
Common Stock
2025-03-28+71,174→ 71,174 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-08−27,350→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-08−27,350→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-08−28,500→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-08−87,440→ 0 total
Disposition from Tender
Poseida Therapeutics, Inc.
Common Stock
2025-01-08−58,950→ 0 total
Award
MAXCYTE, INC.$MXCT
Common Stock
2024-10-14+51,679→ 51,679 total
Award
MAXCYTE, INC.$MXCT
Stock Option (right to buy)
2024-10-14+97,698→ 97,698 total
Award
Poseida Therapeutics, Inc.
Common Stock
2024-06-17+19,650→ 58,950 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to buy)
2024-06-17+27,350→ 27,350 total
Exercise/Conversion
Certara, Inc.$CERT
Common Stock
2024-05-21+8,663→ 24,161 total
Award
Certara, Inc.$CERT
Restricted Stock Units
2024-05-21+11,928→ 11,928 total
Exercise/Conversion
Certara, Inc.$CERT
Restricted Stock Units
2024-05-21−8,663→ 0 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to buy)
2023-06-15+27,350→ 27,350 total
Award
Poseida Therapeutics, Inc.
Common Stock
2023-06-15+19,650→ 39,300 total
Award
DermTech, Inc.
Common Stock
2023-06-01+35,714→ 104,835 total
Award
Certara, Inc.$CERT
Restricted Stock Units
2023-05-23+8,663→ 8,663 total
Exercise/Conversion
Certara, Inc.$CERT
Restricted Stock Units
2023-05-17−9,067→ 0 total
Exercise/Conversion
Certara, Inc.$CERT
Common Stock
2023-05-17+9,067→ 15,498 total
Award
Poseida Therapeutics, Inc.
Common Stock
2022-06-16+19,650→ 19,650 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-16+28,500→ 28,500 total
Award
DermTech, Inc.
Common Stock
2022-05-26+26,480→ 69,121 total
Award
Certara, Inc.$CERT
Restricted Stock Units
2022-05-17+9,067→ 9,067 total
Award
Certara, Inc.$CERT
Common Stock
2021-08-01+6,431→ 6,431 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-07-23+87,440→ 87,440 total
Award
DermTech, Inc.
Common Stock
2021-05-26+4,661→ 42,641 total
Award
DermTech, Inc.
Common Stock
2021-05-26+4,497→ 37,980 total
Sale
Editas Medicine, Inc.$EDIT
Common Stock
2021-02-09$66.65/sh−1,262→ 43,760 total
Sale
Editas Medicine, Inc.$EDIT
Common Stock
2020-08-20$36.66/sh−1,976→ 45,022 total
Award
DermTech, Inc.
Common Stock
2020-06-17+8,000→ 33,483 total
Award
Editas Medicine, Inc.$EDIT
Common Stock
2020-02-06+15,625→ 46,998 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2020-02-06+93,750→ 93,750 total
Award
DermTech, Inc.
Common Stock
2020-01-30+6,000→ 25,483 total
Exercise/Conversion
DermTech, Inc.
Restricted Stock Units
2019-12-31−8,755→ 0 total
Exercise/Conversion
DermTech, Inc.
Common Stock
2019-12-31+8,755→ 19,483 total
Award
Editas Medicine, Inc.$EDIT
Common Stock
2019-09-11+20,000→ 31,373 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2019-09-11+250,000→ 250,000 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2019-09-11+500,000→ 500,000 total
Award
Editas Medicine, Inc.$EDIT
Common Stock
2019-08-19+8,283→ 16,566 total

Companies

Recent Filings

Address

C/O MAXCYTE, INC. 9713 KEY WEST AVENUE, SUITE 400

ROCKVILLE, MD, 20850

View on SEC.gov